| Bioactivity | Incensole acetate is a main constituent of Boswellia carterii resin, has neuroprotective effects against neuronal damage in traumatic and ischemic head injury. Incensole acetate reduces Aβ25–35-triggered apoptosis in hOBNSCs[1]. |
| Invitro | Incensole acetate (100 μM; pre-treatment 4 hours) significantly ameliorates Aβ 25–35-induced cell death, a 48–52% decrease in cell viability at Aβ25–35 is restored to 85–89% upon pre-treatment with IA[1].Incensole acetate (5-100 μM) pretreatment reverses increase in the mRNA and protein level of Bax, caspase 8, cyto c and decrease in the mRNA and protein level of Bcl2 induced by Aβ 25–35 in hOBNSCs[1]. Cell Viability Assay[1] Cell Line: |
| Name | Incensole Acetate |
| CAS | 34701-53-6 |
| Formula | C22H36O3 |
| Molar Mass | 348.52 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | 4°C, protect from light *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light) |
Incensole Acetate
CAS: 34701-53-6 F: C22H36O3 W: 348.52
Incensole acetate is a main constituent of Boswellia carterii resin, has neuroprotective effects against neuronal damage
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.